Company overview
Basic information
Company name
Copylux, MB
Company code
302922300
Registered address
Panevėžio r. sav., Paįstrio sen., Medikonių k., Medikonių g. 15, LT-38400
Registration date
2012-11-26
Company age: 13 y. 11 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
None
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Other printing
Ownership form
Private without foreign capital
Copylux, MB
Company code: 302922300
Address: Panevėžio r. sav., Paįstrio sen., Medikonių k., Medikonių g. 15, LT-38400
Description
This description was generated by artificial intelligence.
Copylux, MB (company code 302922300) is an operational private small partnership registered in 2012. It is classified as a privately owned Lithuanian entity within the national private non-financial companies sector, with governance marked as other. The company is a micro business and operates under EVRK code C.18.12.00, Other printing. Its registered address is in Medikoniu k., Paistrio sen., Panevežio r. sav., Panevežio county.
The latest available financial year is 2024. Revenue amounted to €1.0K, down from €3.0K in 2023, while net profit was €237, compared with €1.5K a year earlier. The profit margin was 23.3% in 2024 and 52.3% in 2023. At year-end 2024, equity remained negative at -€1.1K, liabilities stood at €6.2K, and total assets were €5.1K. No employee or average wage figures are provided in the available data.
The latest available financial year is 2024. Revenue amounted to €1.0K, down from €3.0K in 2023, while net profit was €237, compared with €1.5K a year earlier. The profit margin was 23.3% in 2024 and 52.3% in 2023. At year-end 2024, equity remained negative at -€1.1K, liabilities stood at €6.2K, and total assets were €5.1K. No employee or average wage figures are provided in the available data.
Download a detailed company report
Make confident decisions with all the information about Copylux, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.